v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (1,656) $ (2,903)
Depreciation and amortization 396 554
Stock-based compensation expense 377 427
Gain on equity method investment (101) 0
Gain (loss) on change in fair value 0 90
Other non-cash activities 40 108
Changes in operating assets and liabilities:    
Accounts receivable, net 189 (88)
Inventory 108 (125)
Other assets 38 (63)
Accounts payable and accrued liabilities 120 (257)
Deferred revenues 403 51
Other liabilities (38) 183
Net cash used in operating activities (124) (2,023)
Cash flows from investing activities:    
Purchases of equity securities and short-term investments (1,942) (2,229)
Sales of short-term investments 101 0
Maturities of short-term investments 1,527 1,671
Capital expenditures (800) (537)
Net cash used in investing activities (1,114) (1,095)
Cash flows from financing activities:    
Proceeds from stock-based compensation programs 36 32
Proceeds from issuance of capital stock 750 0
Proceeds from issuance of long-term debt 1,250 0
Repayments of long-term debt (1,250) 0
Proceeds from issuance of convertible notes 0 1,000
Other financing activities (36) (4)
Net cash provided by financing activities 750 1,028
Effect of exchange rate changes on cash and cash equivalents 6 (4)
Net change in cash (482) (2,094)
Cash, cash equivalents, and restricted cash—Beginning of period 5,294 7,857
Cash, cash equivalents, and restricted cash—End of period 4,812 5,763
Supplemental disclosure of non-cash investing and financing activities:    
Capital expenditures included in liabilities 452 365
Capital stock issued to settle bonuses 47 179
Right-of-use assets obtained in exchange for operating lease liabilities $ 134 $ 87